Stock Price Quote

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE664.7020.05 (+3.11 %)
PREV CLOSE ( ) 644.65
OPEN PRICE ( ) 654.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8822
TODAY'S LOW / HIGH ( )642.60 675.05
52 WK LOW / HIGH ( )482 737.8
NSE662.6517.95 (+2.78 %)
PREV CLOSE( ) 644.70
OPEN PRICE ( ) 640.05
BID PRICE (QTY) 662.65 (799)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 159092
TODAY'S LOW / HIGH( ) 640.05 674.40
52 WK LOW / HIGH ( )480 738.1
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX

NEWS

03Feb Board to consider FY19 results & Thir
Natco Pharma Ltd has informed BSE that the meeting of the Board of Direc..
27Jan Announcement under Regulation 30 (LOD
Allotment of Equity Shares under NATCO Employee Stock Option Schemes, 20..
03Jan Natco Pharma files ANDA for Tipiracil
Natco Pharma has submitted an Abbreviated New Drug Application (ANDA) co..
02Jan Announcement under Regulation 30 (LOD
NATCO files ANDA for Trifluridine/ Tipiracil Hydrochloride Tablets for t..
04Dec NITCO, Frontline Corporation and Eris
NITCO has entered into a Non-binding term sheet to appoint Hines India R..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit10366671
Gross Profit 1273 8474
Operating Profit 15769463
Net Sales 447719863

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi India (BSE)
peergroup  7322.90 (2.05%)
M.Cap ( in Cr)16865.09
Ajanta Pharma (BSE)
peergroup  1446.05 (10.03%)
M.Cap ( in Cr)12618.42
Ipca Laboratories (BSE)
peergroup  1456.15 (3.43%)
M.Cap ( in Cr)18398.76
Solara Active Pharma (BSE)
peergroup  680.25 (6.01%)
M.Cap ( in Cr)1772.41
Alkem Laboratories (BSE)
peergroup  2657.75 (1.39%)
M.Cap ( in Cr)31777.39

Shareholding Pattern

MUTUAL FUNDS/UTI 7.9%
PROMOTERS 48.98%
NON-INSTITUTION 19.4%
FI/BANKS/INSURANCE 1.08%
GOVERNMENT 0%
FII 0%

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 664.7. Its current market capitalisation stands at Rs 12102.06 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20945 Cr and Total Income of Rs.22247 Cr. The company's management includes Sridhar Sankararaman, D Linga Rao, MUR Naidu, PSRK Prasad, Leela Digumarti, DG Prasad, Rajeev Nannapaneni, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X